Your browser doesn't support javascript.
loading
ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators.
Cai, Zhonglin; Xu, Huan; Bai, Gang; Hu, Hanjing; Wang, Di; Li, Hongjun; Wang, Zhong.
Afiliación
  • Cai Z; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Xu H; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Bai G; Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Hu H; Department of Biochemistry and Molecular Biology, School of Medicine, Nantong University, Nantong, China.
  • Wang D; Department of Molecular Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
  • Li H; Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Wang Z; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Front Oncol ; 12: 939784, 2022.
Article en En | MEDLINE | ID: mdl-35978821
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China